2025. The Potent and Selective Oral STAT6 Degrader, KT-621, Affects Gene Transcripts in Human Keratinocytes as Effectively as Dupilumab, and Blocks Th2 Inflammation in Atopic Dermatitis and Asthma Mouse Models. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s629. DOI:https://doi.org/10.25251/xbb5zx93.